David Eigen

David Eigen is a seasoned professional with extensive experience in executive leadership and board oversight across various companies. Currently serving as a Board Member at LyfeMD and as a Board Observer at binah.ai and Clarapath, Inc., David Eigen also holds the position of Chief Executive Officer at LEVIANT and Managing Member at P5 Health Ventures. David Eigen possesses a strong educational background, holding a Bachelor of Science in Finance from The Wharton School (1986-1990) and a Juris Doctor from Cardozo School of Law (1991-1993).